FDA Label for Vaqta

View Indications, Usage & Precautions

Vaqta Product Label

The following document was submitted to the FDA by the labeler of this product Bamboo Us Bidco Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Principal Display Panel - 0.5 Ml Vials Carton



10 Single-dose ~25U/0.5-mL Vials

(HEPATITIS A VACCINE, INACTIVATED)
VAQTA ®

PEDIATRIC/ADOLESCENT

0.5 mL vial contains approximately 25U of hepatitis A virus antigen on an Amorphous aluminum
hydroxyphosphate sulfate adjuvant. Hepatitis A virus is grown in cell culture in human MRC-5
diploid fibroblasts.

Rx only


Principal Display Panel - 0.5 Ml Syringes Carton




10 Single-Dose 0.5-mL Syringes

[HEPATITIS A VACCINE,
INACTIVATED]
VAQTA ®

PEDIATRIC/ADOLESCENT
FORMULATION

This package contains 10 single-dose syringes.
Each 0.5-mL syringe contains approximately 25U of hepatitis A virus antigen
on an amorphous aluminum hydroxyphosphate sulfate adjuvant.

Hepatitis A virus is grown in cell culture in human MRC-5 diploid fibroblasts.

Rx only


Principal Display Panel - 1 Ml Syringes Carton



10 Single-Dose 1-mL Syringes

[HEPATITIS A VACCINE,
INACTIVATED]
VAQTA ®

ADULT FORMULATION

This package contains 10 single-dose syringes.
Each 1-mL syringe contains approximately 50U of hepatitis A virus antigen
on an amorphous aluminum hydroxyphosphate sulfate adjuvant.

Hepatitis A virus is grown in cell culture in human MRC-5 diploid fibroblasts.

Rx only


* Please review the disclaimer below.